New Imaging Agent Shown to Detect Aggressive Prostate Cancer in Mouse Study

New Imaging Agent Shown to Detect Aggressive Prostate Cancer in Mouse Study
A new imaging agent appears capable of distinguishing aggressive from benign prostate cancer, potentially helping doctors select with better precision those patients in need of more extensive treatment, a pre-clinical study finds. So far only tested in mice, the imaging agent makes use of a newly identified protein only present in aggressive prostate cancer forms.

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *